Aviva and FNZ unveil latest innovations to enhance adviser experience
Aviva platform continues development of innovative technology to support advisers.The latest innovation,…
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33…
